SCHEMBL8484454

SCHEMBL8484454

CCCCCN(CC(F)(F)F)C(=O)C1c2ccccc2-c2cccc(N3CCC(NC(=O)c4ccccc4)CC3)c21

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ NPSR1 Q6W5P4 1/20 0.42
▸ DRD2 P14416 2/20 0.37
▸ DRD3 P35462 2/20 0.37
▸ CKS1B P61024 1/20 0.37
▸ SKP1 P63208 1/20 0.37
▸ SKP2 Q13309 1/20 0.37
▸ CARM1 Q86X55 1/20 0.37
▸ PRMT6 Q96LA8 1/20 0.37
▸ SLC6A5 Q9Y345 2/20 0.36
▸ UTS2R Q9UKP6 1/20 0.36
▸ MCHR1 Q99705 4/20 0.36
▸ KMT2A Q03164 3/20 0.36
▸ MEN1 O00255 2/20 0.36
▸ CCR3 P51677 1/20 0.36
▸ CNR1 P21554 1/20 0.36
▸ CNR2 P34972 1/20 0.36
▸ ADRA1D P25100 1/20 0.36
▸ ADRA1A P35348 1/20 0.36
▸ ADRA1B P35368 1/20 0.36
▸ SCN1A P35498 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8485533 0.98 NPSR1 (0.42) NPSR1DRD2DRD3CKS1BSKP1
SCHEMBL8666092 0.95 UTS2R (0.39) NPSR1DRD2CKS1BSKP1SKP2
SCHEMBL8665880 0.93 UTS2R (0.39) NPSR1DRD2CKS1BSKP1SKP2
SCHEMBL8501048 0.92 NPSR1 (0.35) NPSR1UTS2RSCN9AHTR2A
SCHEMBL8501233 0.90 NPSR1 (0.36) NPSR1DRD2DRD3UTS2RSCN9A
SCHEMBL8712537 0.89 CCR3 (0.43) NPSR1DRD2KMT2AMEN1CCR3
SCHEMBL8717870 0.88 NPSR1 (0.38) NPSR1DRD2DRD3CKS1BSKP1
SCHEMBL8713180 0.87 CKS1B (0.41) DRD2CKS1BSKP1SKP2MCHR1
SCHEMBL8717983 0.87 CCR3 (0.43) NPSR1DRD2KMT2AMEN1CCR3
SCHEMBL8483684 0.86 NPSR1 (0.41) NPSR1DRD2DRD3CKS1BSKP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5883099-A TREATMENT OF ATHERSCLEROSIS, PANCREATITIS OBESITY OR HYPERGLYCEMIA BRISTOL-MYERS SQUIBB COMPANY (US) 1999-03-16 — — US disclosed
US-5739135-A PREVENTING OR TREATING ATHEROSCLEROSIS, PANCREATITIS SECONDARY TO HYPERTRIGLYCERIDEMIA, HYPERGLYCEMIA, OBESITY BRISTOL-MYERS SQUIBB COMPANY (US) 1998-04-14 — — US disclosed
Send feedback